Related Experiment Video
Updated: Sep 6, 2025

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
Published on: August 18, 2023
Impact of sleep apnea and treatments on cardiovascular disease
Andre Faria1, Arthur Macedo1, Carolina Castro1
1Universidade Federal de Minas Gerais, Faculdade de Medicina - Belo Horizonte - MG - Brazil.
Insights
Obstructive sleep apnea (OSA) is a significant risk factor for cardiovascular diseases (CVDs), including hypertension, atrial fibrillation, stroke, and heart failure. Treating OSA may reduce the incidence of these serious cardiovascular complications.
Area of Science:
- Cardiology
- Sleep Medicine
- Public Health
Background:
- Cardiovascular diseases (CVDs) represent a major global health burden, causing millions of deaths annually.
- Understanding risk factors for CVDs is crucial for effective prevention and treatment strategies.
- Sleep-disordered breathing, particularly obstructive sleep apnea (OSA), is increasingly recognized as a potential contributor to CVDs.
Purpose of the Study:
- To review epidemiological data linking obstructive sleep apnea (OSA) with major cardiovascular outcomes.
- To explore the proposed pathophysiological mechanisms connecting OSA and cardiovascular diseases.
- To discuss the impact of OSA treatments on cardiovascular complication prevalence.
Main Methods:
- Systematic review of epidemiological studies.
- Analysis of proposed biological pathways and mechanisms.
- Evaluation of evidence on therapeutic interventions for OSA and their cardiovascular effects.
Main Results:
- Significant associations found between OSA and increased risk of hypertension, atrial fibrillation, stroke, atherosclerosis, and heart failure.
- Multiple biological pathways identified, including inflammation, oxidative stress, and sympathetic nervous system activation, link OSA to cardiovascular disease.
- Evidence suggests that treating OSA can mitigate the risk and prevalence of cardiovascular complications.
Conclusions:
- Obstructive sleep apnea is a significant and modifiable risk factor for a wide range of cardiovascular diseases.
- Targeting OSA through appropriate treatments offers a promising strategy to reduce the global burden of cardiovascular mortality and morbidity.
Abstract:
Cardiovascular diseases (CVDs) are the leading causes of mortality worldwide, accounting for nearly 18 million deaths per year. Among other considerations, treating CVDs requires better understanding their risk factors. Sleep-disordered breathing, especially obstructive sleep apnea (OSA), is a likely contributor to several CVDs. We review key epidemiological data that addresses the link between OSA and cardiovascular outcomes such as hypertension, atrial fibrillation (AF), stroke, atherosclerosis, and heart failure (HF), and proposed pathophysiological mechanisms underlying this association. There are several biological pathways linking OSA and an increased propensity to cardiovascular diseases, and we discuss the evidence on the benefits of treatments of OSA on the prevalence of cardiovascular complications.
More Related Videos
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
07:54Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Coronary Artery Disease I: Introduction
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Heart Failure VI: Adjunct Therapies
Other Pulmonary Disorders
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...